Pseudo-fovea formation after gene therapy for RPE65-LCA.
about
Gene therapy of inherited retinal degenerations: prospects and challengesGene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 AchromatopsiaPupillary Light Reflexes in Severe Photoreceptor Blindness Isolate the Melanopic Component of Intrinsically Photosensitive Retinal Ganglion Cells.Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials.Improvement in vision: a new goal for treatment of hereditary retinal degenerationsOuter Plexiform Layer Structures Are Not Altered Following AAV-Mediated Gene Transfer in Healthy Rat RetinaRetinal Gene Therapy: Current Progress and Future Prospects.Non-viral therapeutic approaches to ocular diseases: An overview and future directionsLet There Be Light: Gene and Cell Therapy for Blindness.Developing an Outcome Measure With High Luminance for Optogenetics Treatment of Severe Retinal Degenerations and for Gene Therapy of Cone DiseasesPostretinal Structure and Function in Severe Congenital Photoreceptor Blindness Caused by Mutations in the GUCY2D Gene.Correction of Monogenic and Common Retinal Disorders with Gene Therapy.Timing of Antioxidant Gene Therapy: Implications for Treating Dry AMD.Visual Cortex Plasticity Following Peripheral Damage To The Visual System: fMRI Evidence.Stability and compatibility of recombinant adeno-associated virus under conditions commonly encountered in human gene therapy trials.Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.
P2860
Q27009261-148994FD-3DD2-4411-BEAF-B70AE6F72ACBQ27318262-E9ACB966-05E0-473F-86C1-E70B5F79374BQ32186770-05192A80-8984-4DAC-9737-0E1579821A80Q34473512-134B2BF6-B02D-430B-846E-B37BD4268FB6Q35805426-67047130-4C22-4C01-91D3-1E64307D8385Q36303580-4DFDED73-93ED-4CA9-B9C0-5491025C0D7BQ36306263-3EC3E430-0A71-455A-9D52-6FC8CAEB38C7Q36425890-9C2CCBE1-20F2-403B-BCA8-1ECDC5905F09Q36654534-D939CF7E-E739-413B-8D7A-95014A6746F5Q37055754-FD7605C2-61B4-4243-ACBA-58327F5B6383Q37641855-38C2784D-49B5-449F-BC91-DB89E1B955E2Q37676230-C2EF172D-1FD9-4C65-AB22-4FD31A62F11FQ37682509-D37E987A-862B-4D9C-AA06-3D61052C1C2CQ38932300-1DE2A40C-F147-4C74-B2FF-E98169351FEDQ39024016-ACD276E5-E873-4271-85C6-77CE1B50CF6AQ45875451-86EED38D-DC4F-4931-BAA7-D5E849451299
P2860
Pseudo-fovea formation after gene therapy for RPE65-LCA.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@ast
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@en
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@nl
type
label
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@ast
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@en
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@nl
prefLabel
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@ast
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@en
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@nl
P2093
P2860
P356
P1476
Pseudo-fovea formation after gene therapy for RPE65-LCA.
@en
P2093
Alejandro J Roman
Artur V Cideciyan
Geoffrey K Aguirre
Malgorzata Swider
Omar H Butt
Sam Sadigh
Sharon B Schwartz
P2860
P304
P356
10.1167/IOVS.14-15895
P407
P577
2014-12-23T00:00:00Z